GOHEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.15 USD | +1.40% |
|
-3.33% | -23.91% |
| Sales 2024 * | 742M 61.89B | Sales 2025 * | 780M 65.05B | Capitalization | 101M 8.42B |
|---|---|---|---|---|---|
| Net income 2024 * | -50M -4.17B | Net income 2025 * | -43M -3.59B | EV / Sales 2024 * | 0.14 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.13 x |
| P/E ratio 2024 * |
-1.91
x | P/E ratio 2025 * |
-2.29
x | Employees | 2,530 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 17.48% |
More Fundamentals
* Assessed data
More news
Latest transcript on GoHealth, Inc.
More recommendations
More press releases
| 1 day | +1.40% | ||
| 1 week | -3.33% | ||
| Current month | -3.43% | ||
| 1 month | -6.97% | ||
| 3 months | -16.05% | ||
| 6 months | -19.57% | ||
| Current year | -23.91% |
1 week
9.63
10.46
1 month
9.3011.00
Current year
9.0814.19
1 year
7.7022.85
3 years
4.94185.85
5 years
4.94393.75
10 years
4.94393.75
| Managers | Title | Age | Since |
|---|---|---|---|
Vijay Kotte
CEO | Chief Executive Officer | 46 | 06/22/06 |
Clinton Jones
FOU | Founder | 46 | 01/01/01 |
Brandon Cruz
FOU | Founder | 46 | 01/01/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Fisher
BRD | Director/Board Member | 54 | 25/22/25 |
Joseph Flanagan
BRD | Director/Board Member | 52 | 01/20/01 |
Brandon Cruz
FOU | Founder | 46 | 01/01/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 10.15 | +1.40% | 10,266 |
| 25/24/25 | 10.01 | -0.40% | 8,312 |
| 24/24/24 | 10.05 | -0.89% | 18,717 |
| 23/24/23 | 10.14 | +4.11% | 18,633 |
| 22/24/22 | 9.74 | -7.24% | 6,950 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotes
GoHealth, Inc. is a medicare-focused digital health company that operates a health insurance marketplace. The Company primarily offers Medicare plans, including, Medicare Advantage, Medicare Supplement and prescription drug plans. Its technology platform leverages modern machine-learning algorithms powered by insurance behavioral data to reimagine the optimal process for helping consumers find the health plan for their specific needs. Its Medicare Advantage offerings include Special Needs Plans (SNPs). SNPs are special kinds of Medicare Advantage plans that have benefits covering special health care or financial needs. Its Marketplace technology features decision support tools and integrates with health plan partner enterprise systems, enabling agents to quickly select the right health insurance plan for each consumer based on their specific needs and enroll them in those plans. It offers Encompass Connect and Encompass Engage services to its health plan partners.
Calendar
09/05/2024
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
10.15
USD
Average target price
18.33
USD
Spread / Average Target
+80.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -23.91% | 101M | |
| +4.10% | 51.16B | |
| +4.04% | 25.66B | |
| +14.55% | 23.24B | |
| +26.59% | 9.56B | |
| +13.76% | 5.81B | |
| -4.12% | 4.02B | |
| +1.30% | 1.99B | |
| +11.16% | 1.76B | |
| -26.78% | 1.4B |
- Stock Market
- Equities
- GOCO Stock
